Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Medori

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional areaR Medori, L Autilio-Gambetti, S Monaco, et al.
Neurology|April 1, 1988
Changes in axon size and slow axonal transport are related in experimental diabetic neuropathyR Medori, L Autilio-Gambetti, H Jenich, et al.
Italian Journal of Neurological Sciences|February 1, 1987
Cranial bone density in motor neuron disease (MND)P Montagna, R Liguori, R Medori, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 26, 2008
Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 monthsP-M Llorca, E Sacchetti, K Lloyd, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Long-acting risperidone improves negative symptoms in stable psychotic patientsV A Curtis, K Katsafouros, H-J Möller, et al.
Bulletin Europeen De Physiopathologie Respiratoire|March 1, 1984
A polygraphic study of one case of primary alveolar hypoventilation (Ondine's curse)C Coccagna, F Cirignotta, M Zucconi, et al.
Toxicology and Applied Pharmacology|June 15, 1986
Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formationL M Sayre, C M Shearson, T Wongmongkolrit, et al.
Minerva Pediatrica|March 1, 1991
[Clinical,manifestations of the myopathies due to deletions/mutations of the dystrophin gene]E Bonilla, C Minetti, H W Chang, et al.
Electroencephalography and Clinical Neurophysiology|August 1, 1989
The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degenerationP Tinuper, P Montagna, R Medori, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapineM Gastpar, M Masiak, M A Latif, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional areaR Medori, L Autilio-Gambetti, S Monaco, et al.
Neurology|April 1, 1988
Changes in axon size and slow axonal transport are related in experimental diabetic neuropathyR Medori, L Autilio-Gambetti, H Jenich, et al.
Italian Journal of Neurological Sciences|February 1, 1987
Cranial bone density in motor neuron disease (MND)P Montagna, R Liguori, R Medori, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 26, 2008
Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 monthsP-M Llorca, E Sacchetti, K Lloyd, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Long-acting risperidone improves negative symptoms in stable psychotic patientsV A Curtis, K Katsafouros, H-J Möller, et al.
Bulletin Europeen De Physiopathologie Respiratoire|March 1, 1984
A polygraphic study of one case of primary alveolar hypoventilation (Ondine's curse)C Coccagna, F Cirignotta, M Zucconi, et al.
Toxicology and Applied Pharmacology|June 15, 1986
Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formationL M Sayre, C M Shearson, T Wongmongkolrit, et al.
Minerva Pediatrica|March 1, 1991
[Clinical,manifestations of the myopathies due to deletions/mutations of the dystrophin gene]E Bonilla, C Minetti, H W Chang, et al.
Electroencephalography and Clinical Neurophysiology|August 1, 1989
The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degenerationP Tinuper, P Montagna, R Medori, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapineM Gastpar, M Masiak, M A Latif, et al.
Pageof 5